Meta-Analytic Review of High Anxiety Comorbidity among Patients with Vitiligo.
Meta-Analytic Review of High Anxiety Comorbidity among Patients with Vitiligo.
复制标题
白癜风患者高度焦虑合并症的荟萃分析综述
DOI:
10.1155/2021/6663646
复制
发表时间:
2021
影响因子:
--
通讯作者:
Xiao R
中科院分区:
文献类型:
--
作者:
Liu J;Tang R;Xiao Y;Luo M;Shi Y;Deng Q;Zhang H;Zeng Z;Pi Z;Xiao R
Vitiligo is a disfiguring skin disease with profound psychosocial impacts, such as anxiety, but the reported effect sizes of associations vary. We aimed to conduct a meta-analysis to quantify the strength of association between anxiety and vitiligo and to estimate the prevalence of anxiety among individuals with vitiligo. A systematic literature search was performed in five online databases (MEDLINE, Embase, Web of Science, Cochrane Library, and PsycINFO) from inception until March 20, 2020. All of the eligible studies were comprehensively reviewed, and all of the available data were analyzed according to our predefined criteria. Twenty-one studies involving 3259 patients in 11 countries were included in this meta-analysis. Compared with the healthy control group, patients with vitiligo often had concomitant anxiety (OR = 6.14 [95% CI: 3.35–11.24], I2 = 30.1%). The pooled prevalence of anxiety in female patients was significantly higher than that in males (OR = 2.24 [95% CI: 1.31–3.84], I2 = 0.0%). Subgroup analysis showed that the pooled prevalence of clinical anxiety disorder and anxiety symptoms was 12% (95% CI: 7%–16%, I2 = 76.3%) and 34% (95% CI: 21%–46%, I2 = 94.7%), respectively. No publication bias has been detected by Begg's funnel plot and Egger's test. Patients with vitiligo have high anxiety comorbidity, with female predominance. Dermatologists and psychiatrists should be vigilant to the presence of anxiety, apply appropriate interventions to reduce the psychological impacts in a timely manner, and thus promote recovery in vitiligo patients. However, due to some objective limitations (poor information about the OR and diversity in assessment tools among included studies), findings should be interpreted with caution.
登录
查看更多内容
影响因子:
2.3
作者:
AlShahwan, Mohammed A.
通讯作者:
AlShahwan, Mohammed A.
DOI:
10.1136/bmj.b2535
发表时间:
2009-07-21
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Moher D;Liberati A;Tetzlaff J;Altman DG;PRISMA Group
通讯作者:
PRISMA Group
影响因子:
3.6
作者:
Karelson, Maire;Silm, Helgi;Kingo, Kuelli
通讯作者:
Kingo, Kuelli
影响因子:
3.6
作者:
Krueger, Christian;Schallreuter, Karin Uta
通讯作者:
Schallreuter, Karin Uta
DOI:
10.1111/jdv.15255
发表时间:
2019-01-01
影响因子:
9.2
作者:
Patel, K. R.;Singam, V.;Silverberg, J. I.
通讯作者:
Silverberg, J. I.